Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions (FSS-EDICT I)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The hypotheses of the present study of Freeman-Sheldon syndrome (FSS) and related conditions are: (1) that exercise capacity is lower in FSS patients versus normal controls, and the lower exercise capacity is due to changes in the muscles' normal structure and an inability of sufficient quantity of the energy molecule to bind to muscle; (2) this muscle problem reduces amount of air that can get in the lung and amount of oxygen carried in the blood, which then has the effect of increasing heart and respiration rates, blood pressure, and deep body temperature, and produces muscle rigidity; (3) the events noted above, when they occur during cardiac stress testing, are related to a problem similar to malignant hyperthermia (MH) reported in some muscle disorders without use of drugs known to cause MH. MH (a life-threatening metabolic reaction that classically is triggered when susceptable persons receive certain drugs used in anaesthesia.
| Condition | Intervention |
|---|---|
|
Arthrogryposis Craniofacial Abnormalities |
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels Procedure: Physiological Stress Test Other: Functional Enquiry Form Other: Strength, Joint ROM, Girth and Length Measurements Other: Study Physical Examination Other: Observational Gait Analysis Other: Mental Health Interview |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Freeman-Sheldon Syndrome Evaluation and Diagnosis in Clinical Settings (FSS-EDICT) I: a Case-Control, Cross-Sectional Study of Baseline and Stress Physiology Parameters |
- Heart rate [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Increased heart rate is used as an index of cardiovascular strain.
- Non-Invasive Arterial Blood Pressure [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Increased non-invasive arterial blood pressure rate is used as an index of cardiovascular strain.
- Lung Volumes [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Decreased lung volumes are used as an index of strain caused by Freeman-Sheldon syndrome and related conditions.
- Saturation of Peripheral Oxygen [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Decreased saturation of peripheral oxygen is used as an index of strain caused by Freeman-Sheldon syndrome and related conditions.
- Respiratory Rate [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Increased respiratory rate is used as an index of cardiovascular strain.
- Electrocardiogram Tracings [ Time Frame: Evaluated during two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: Yes ]Electrocardiogram tracings are used as an index of cardiovascular strain.
- Oesophageal (Core) Temperature [ Time Frame: Evaluated at rest and while exercising, during second of two study visits (lasting an average of 1-3 hours) ] [ Designated as safety issue: Yes ]Increased oesophageal (core) temperature is used as an index of cardiovascular strain.
- Adenosine Triphosphate Blood Levels [ Time Frame: Evaluated at rest and while exercising, during second of two study visits (lasting an average of 1-3 hours) ] [ Designated as safety issue: No ]Adenosine triphosphate blood levels are used as an index of strain caused by Freeman-Sheldon syndrome and related conditions.
- Borg Scale Ratings of Perceived Exertion [ Time Frame: Evaluated while exercising, during second of two study visits (lasting an average of 1-3 hours) ] [ Designated as safety issue: No ]Increased Borg scale ratings of perceived exertion are used as an index of fatigue.
- Muscle Rigidity [ Time Frame: Evaluated while exercising, during second of two study visits (lasting an average of 1-3 hours) ] [ Designated as safety issue: Yes ]Increased Muscle rigidity is used as an indicator of malignant hyperthermia, when increased core temperature, heart, and respiratory rate are present.
- Medical Outcomes Trust Short Form (36) Health Survey (SF-36) [ Time Frame: Evaluated in first of two study visits, lasting an average of 1-3 hours ] [ Designated as safety issue: No ]Medical Outcomes Trust Short Form (36) Health Survey (SF-36) will be used to assess physical quality of life, which correlates strongly with physical exercise capacity.
Biospecimen Retention: None Retained
Blood samples will be taken but no retention is expected.
| Estimated Enrollment: | 20 |
| Study Start Date: | February 2011 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Syndrome Group
Individuals with Freeman-Sheldon, Sheldon-Hall, distal arthrogryposis type 1, or distal arthrogryposis type 3
|
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels
Completed during the clinical examination and exercise test by the researchers, lactate, glucose, and free and total adenosine triphosphate blood levels are determined at rest and during exercise.
Other Names:
Procedure: Physiological Stress Test
During exercise, heart and lung function are monitored for changes caused by exercise, which increases the body's need for oxygen and puts extra demands on the heart. In this study, testing is done using a cycle ergometer and conducted according to the standardised exponential exercise protocol (STEEP).
Other Names:
Other: Functional Enquiry Form
Evaluated before clinical examination, it is a checklist of medical problems.
Other Names:
Other: Strength, Joint ROM, Girth and Length Measurements
Completed during the clinical examination by the researchers, it is a structured approach to evaluation of muscles, joints, arms, thighs, and legs.
Other Names:
Other: Study Physical Examination
Completed during the clinical examination by the researchers, it is a structured approach to a full physical examination (minus breasts, genitalia, or rectum).
Other Names:
Other: Observational Gait Analysis
Completed during the clinical examination by researchers, it is a structured approach to evaluation of a person's walking.
Other Names:
Other: Mental Health Interview
Completed during the clinical examination by the researchers, it is a general evaluation of mental health status.
Other Names:
|
|
Control Group
Healthy individuals
|
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels
Completed during the clinical examination and exercise test by the researchers, lactate, glucose, and free and total adenosine triphosphate blood levels are determined at rest and during exercise.
Other Names:
Procedure: Physiological Stress Test
During exercise, heart and lung function are monitored for changes caused by exercise, which increases the body's need for oxygen and puts extra demands on the heart. In this study, testing is done using a cycle ergometer and conducted according to the standardised exponential exercise protocol (STEEP).
Other Names:
Other: Functional Enquiry Form
Evaluated before clinical examination, it is a checklist of medical problems.
Other Names:
Other: Strength, Joint ROM, Girth and Length Measurements
Completed during the clinical examination by the researchers, it is a structured approach to evaluation of muscles, joints, arms, thighs, and legs.
Other Names:
Other: Study Physical Examination
Completed during the clinical examination by the researchers, it is a structured approach to a full physical examination (minus breasts, genitalia, or rectum).
Other Names:
Other: Observational Gait Analysis
Completed during the clinical examination by researchers, it is a structured approach to evaluation of a person's walking.
Other Names:
Other: Mental Health Interview
Completed during the clinical examination by the researchers, it is a general evaluation of mental health status.
Other Names:
|
Show Detailed Description
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Patients world-wide are welcome, so-long as they have a qualifying diagnosis. Healthy controls are welcome world-wide, as well.
Syndrome Group Inclusion Criteria:
- Freeman-Sheldon syndrome,
- Sheldon-Hall syndrome,
- Distal arthrogryposis type 1, or
- Distal arthrogryposis type 3
- Deceased patients with enough clinical information available to satisfy study requirements
Syndrome Group Exclusion Criteria:
- Individuals not confirmed to have a condition under study
- Deceased patients without enough clinical information available to satisfy study requirements
- Patients with other anomalies, not having one of the above syndromes
- Patients or parents of minor children not willing to give consent
- Mature female patients who are pregnant or breast-feeding will be reassessed for consideration for enrolment.
- Mature female patients who are currently experiencing menses will be reassessed for consideration for enrolment.
- Patients with active, acute comorbid illness will be reassessed for consideration for enrolment.
Control Group Inclusion Criteria:
- Subjects must be healthy and free of active disease.
- Subject or parent of minor child must be willing to give consent.
- Subjects must fall within the age-bracket to be matched with a Syndrome Group patient already screened and enroled in the study
- Subjects must be non-tobacco users and non-drinkers.
Control Group Exclusion Criteria:
- Subjects exceptional for their age in body weight, stature, or habitus according to commonly accepted guidelines
- Subjects with active psychiatric illness, as manifested by abnormal mental status examination
- Subjects with active physical illness, especially respiratory or cardiac problem, as manifested by abnormal findings on physical examination
- Subjects with significant diagnosis of a constitutional disease or genetic disorder
- Subjects with a history of severe trauma resulting in either an anatomical of physiological deformity that impairs function
- Non-living subjects
- Candidates who fail the stress test
- Mature female subjects who are pregnant or breast-feeding will be reassessed for consideration for enrolment.
- Mature female subjects who are currently experiencing menses will be reassessed for consideration for enrolment.
- Subjects with active, acute illness will be reassessed for consideration for enrolment.
- Any other condition or anomaly expected to affect current physiology listed in AFI-48-123.
Contacts and Locations| Contact: Gerald P Perman, MD | 202-331-8213 | gpperman@gmail.com |
| Contact: Mikaela I Poling, BA | 304-460-9038 | poling_mi@fsrgroup.org |
| United States, West Virginia | |
| Freeman-Sheldon Research Group, Inc. Headquarters | Recruiting |
| Buckhannon, West Virginia, United States, 26201 | |
| Contact: Gerald P Perman, MD 202-331-8213 gpperman@gmail.com | |
| Contact: Mikaela I Poling, BA 304-460-9038 poling_mi@fsrgroup.org | |
| Principal Investigator: Rodger J McCormick, DEd, MS | |
| Sub-Investigator: Robert L Chamberlain, MD | |
| Sub-Investigator: Gerald P Perman, MD | |
| Sub-Investigator: Mikaela I Poling, BA | |
| Principal Investigator: | Rodger J McCormick, DEd, MS | Freeman-Sheldon Research Group, Inc. |
More Information
Additional Information:
Publications:
| Responsible Party: | Freeman-Sheldon Research Group, Inc. |
| ClinicalTrials.gov Identifier: | NCT01306994 History of Changes |
| Other Study ID Numbers: | 000079, U1111-1120-5931 |
| Study First Received: | February 26, 2011 |
| Last Updated: | October 28, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Freeman-Sheldon Research Group, Inc.:
|
Exercise Test Bicycle Ergometry Test Stress Test |
Additional relevant MeSH terms:
|
Arthrogryposis Congenital Abnormalities Craniofacial Dysostosis Craniofacial Abnormalities Joint Diseases Musculoskeletal Diseases Muscular Diseases Musculoskeletal Abnormalities Dysostoses Bone Diseases, Developmental Bone Diseases |
Adenosine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Anti-Arrhythmia Agents Cardiovascular Agents Vasodilator Agents |
ClinicalTrials.gov processed this record on May 21, 2013